Can You Lose Weight by Taking Ozempic? Clinical Evidence

Last reviewed: June 2, 2026

Last updated: June 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, Ozempic (semaglutide) can support weight loss in eligible patients. Clinical trials show average weight reductions of 6-15% over 68 weeks, though individual outcomes vary considerably based on baseline health, adherence, and underlying metabolic factors.

Weight loss with GLP-1 medications involves complex mechanisms—appetite signaling, satiety timing, and gastric motility. Understanding how your genetic profile may influence response to these pathways can support a more personalized conversation with your provider about treatment suitability and expectations.

How GLP-1 Medications Support Weight Loss at the Cellular Level

GLP-1 receptor agonists work by mimicking glucagon-like peptide-1, a hormone regulating appetite and blood sugar. When activated, GLP-1 receptors signal the brain to reduce hunger, increase feelings of fullness, and slow stomach emptying—collectively supporting reduced caloric intake without requiring willpower-based restriction.

This mechanism is distinct from older weight loss drugs. Rather than stimulating metabolism or blocking nutrient absorption, GLP-1 medications modify how your body perceives hunger and satiety. The effect typically develops gradually over weeks, with appetite suppression becoming more pronounced as doses increase.

Clinical Evidence: What Trials Show About Weight Loss Outcomes

Multiple randomized controlled trials demonstrate measurable weight loss with semaglutide and tirzepatide. The STEP trials (semaglutide) showed 6-18% weight reduction depending on dose and population. The SURMOUNT trials (tirzepatide) showed 16-22% reductions. However, outcomes depend on medication adherence, lifestyle factors, and individual metabolic response.

Trial / Medication	Patient Population	Average Weight Loss	Duration
STEP 1 (Semaglutide)	Obese, non-diabetic	10.2% at 1.0mg dose	68 weeks
STEP 2 (Semaglutide)	Obese with cardiovascular disease	9.4% at 1.0mg dose	68 weeks
SURMOUNT-1 (Tirzepatide)	Obese, non-diabetic	20.9% at 15mg dose	72 weeks
SURMOUNT-2 (Tirzepatide)	Type 2 diabetes	22.2% at 15mg dose	84 weeks

Factors That Influence Individual Weight Loss Response

Not everyone loses the same amount of weight on GLP-1 medications. Factors including baseline BMI, insulin sensitivity, medication adherence, diet quality, physical activity, age, and genetic variation in GLP-1 receptor expression all influence outcomes. Some patients achieve 20%+ weight loss; others experience more modest reductions.

Genetic variation in key appetite and metabolic pathways—including GIPR, FTO, and MC4R—can shape how your body responds to these medications. Understanding your predisposition in these pathways may help contextualize expected outcomes and support more realistic goal-setting with your healthcare team.

Who Should Consider This Treatment and Important Safety Considerations

GLP-1 medications are prescribed for weight loss in adults with BMI ≥30 kg/m², or ≥27 kg/m² with weight-related conditions. However, contraindications include personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome, and certain gastrointestinal conditions. Pregnancy and breastfeeding are contraindications.

Common side effects include nausea, vomiting, diarrhea, and constipation—typically transient. Rare but serious risks include pancreatitis, gallbladder issues, and retinopathy changes in diabetic patients. A qualified healthcare provider must evaluate your full medical history, current medications, and weight loss goals before initiating treatment.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals your predispositions in four key peptide pathway genes: GIPR, FTO, and MC4R. These variants may help provide context about how your body's appetite signaling and metabolic regulation pathways function, potentially supporting a more informed discussion with your provider about GLP-1 response expectations.

The test identifies whether you carry common variants associated with stronger or weaker signaling in GLP-1 and GIP receptor pathways, as well as genes affecting satiety perception and energy balance. Understanding your genetic profile does not predict your exact medication response—individual outcomes depend on many factors—but it can support interpretation of clinical trial data in the context of your specific biology.

If you and your provider are considering GLP-1 treatment, the Precision Peptide Genetic Test ($298) can help generate a data-informed conversation about whether GLP-1 medications align with your genetic predispositions and lifestyle capacity for sustained treatment.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How does a GLP-1 differ from older generations of weight loss drugs?

Rather than stimulating metabolism or blocking nutrient absorption, GLP-1 medications change how the body perceives hunger and satiety. The post describes receptor activation signaling the brain to reduce hunger, increase fullness, and slow stomach emptying, which lowers caloric intake without depending on willpower-based restriction. It also notes the effect builds gradually over weeks rather than arriving all at once.

How gradually does the appetite effect described here build up?

Gradually, over weeks rather than immediately. The post says appetite suppression becomes more pronounced as doses increase, which is why the early part of treatment can feel different from later stages. It does not promise a week-by-week schedule, and how any individual moves through a titration is a matter for the prescriber who is monitoring them.

What besides the medication itself shapes how much weight is lost?

The post lists baseline BMI, insulin sensitivity, medication adherence, diet quality, physical activity, and age as influences on the outcome. It stresses that results range widely, with some patients reaching reductions above twenty percent while others see far more modest changes on the same class of drug. That range is why it frames goal-setting as a conversation with a healthcare team.

What BMI thresholds does this post give for GLP-1 prescribing?

It describes these medications as prescribed for weight loss in adults with a BMI of 30 or above, or 27 or above when a weight-related condition is present. Those thresholds act as a starting filter rather than a guarantee of eligibility, because the post also lists contraindications that override them. A qualified provider evaluates the full medical history before any treatment begins.

Which side effects are transient and which are the serious ones?

Nausea, vomiting, diarrhea, and constipation are described as common and typically transient. Rare but serious risks named in the post include pancreatitis, gallbladder issues, and retinopathy changes in patients with diabetes. Contraindications listed include pregnancy, breastfeeding, certain gastrointestinal conditions, and a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.